0 2 year decreases in the last period Trends over the 17 year period Figure 3 16 are intermediate to the estimates for the first 11 years and for the last 12 years
cost of the drug which is necessary to avoid intra stent thrombosis in the first six months would represent one third 1 3 of total amount The results of scenario 1 are shown in Table 2 The intermediate scenario with 40 inclusion of the drug eluting stent represents an increase in the SUS budget by approximately 20 1 in the first year of the procedure The
